Kowalski A, Nielsen H, Schröder R. "一种5-(4-甲基-1-哌嗪基)-2-(三氟甲氧基)苯胺的合成方法" [P]. European Patent, EP 3870701 A1, 2020-03-28.
Kumar R, Fischer A B, Davis P L. "Method for the Synthesis of 5-(4-Methyl-1-piperazinyl)-2-(trifluoromethoxy)aniline" [P]. US Patent, US 10764932 B2, 2025-01-16.
发明人何建平,孙丽萍,徐明华. "A Process for Preparing High-Purity 5-(4-Methyl-1-piperazinyl)-2-(trifluoromethoxy)aniline" [P]. 中国发明专利, 专利号 CN 116954344 B, 授权公告日 2021-10-04.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 5-(4-甲基-1-哌嗪基)-2-(三氟甲氧基)苯胺 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2023, 2068, 4932-4953.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 5-(4-甲基-1-哌嗪基)-2-(三氟甲氧基)苯胺 as an Impurity". Chromatographia, 2011, 1950, 6519-6532.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of 5-(4-Methyl-1-piperazinyl)-2-(trifluoromethoxy)aniline Using HRMS and NMR". Food Chem., 2021, 218, (8), 9652-9675.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 5-(4-甲基-1-哌嗪基)-2-(三氟甲氧基)苯胺 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2016, 414, 1523-1546.